PTC Therapeutics (P91) Q2 2026 Earnings Report
CH:P91 Q2 2026 EPS Results
- Actual EPS
- CHF 0.76
- Consensus EPS
- CHF 0.19
- Beat/Miss
- Beat by +CHF 0.56
- One Year Ago EPS
- -CHF 0.68
CH:P91 Q2 2026 Revenue Results
- Actual Revenue
- CHF 297.36M
- Expected Revenue
- CHF 246.31M
- Beat/Miss
- Beat by +CHF 51.04M
- YoY Revenue Growth
- +101.55%
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 07/30/2026
- Time
- After Close
- Conference Call
- Thursday, July 30, 2026
CH:P91 Upcoming Earnings
PTC Therapeutics's next earnings date is estimated for February 23, 2027, based on past reporting schedules.
Q2 2026 Earnings Call Audio
CH:P91 Q2 2026 Earnings Call
0:00 / 0:00
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
CH:P91 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 23, 2027 | 2026 (Q4) | 0.23- | -1.38 | ― | ― |
| Oct 29, 2026 | 2026 (Q3) | 0.12-0.51 | 0.16 | -410.00% (-0.68) | |
| Jul 30, 2026 | 2026 (Q2) | 0.190.76 | -0.68 | 210.84% (+1.44) | |
| May 07, 2026 | 2026 (Q1) | -0.39-0.02 | 8.28 | -100.30% (-8.31) | |
| Feb 19, 2026 | 2025 (Q4) | 0.08-1.38 | -0.7 | -96.47% (-0.68) | |
| Nov 04, 2025 | 2025 (Q3) | -0.930.16 | -1.15 | 114.39% (+1.31) | |
| Aug 07, 2025 | 2025 (Q2) | -0.84-0.68 | -1.06 | 35.66% (+0.38) | |
| May 06, 2025 | 2025 (Q1) | -0.838.28 | -0.99 | 936.67% (+9.27) | |
| Feb 27, 2025 | 2024 (Q4) | -0.45-0.70 | -1.7 | 58.74% (+1.00) | |
| Nov 07, 2024 | 2024 (Q3) | -1.25-1.15 | -1.45 | 21.02% (+0.31) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
